Joshua Ventura, PHD | |
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
(509) 663-8711 | |
Not Available |
Full Name | Joshua Ventura |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 8 Years |
Location | 820 N Chelan Ave, Wenatchee, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700130739 | NPI | - | NPPES |
1700130739 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | PY60746288 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Washington Health Services Association | 4880504596 | 645 |
News Archive
As part of an annual Orthopedic Surgery Mission to St. Vincent & the Grenadines, a young girl from St. Vincent in the Caribbean has received a rare in-country complex repair procedure for her spine after waiting several years on a waiting list to come to the US for treatment.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Scientists and health officials are increasing efforts to curb a drug-resistant malaria strain along the Thai-Cambodian border that is becoming increasingly resistant to artemisinin, an ingredient in artemisinin-based combination therapies, IRIN News reports.
› Verified 4 days ago
Entity Name | Central Washington Health Services Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
As part of an annual Orthopedic Surgery Mission to St. Vincent & the Grenadines, a young girl from St. Vincent in the Caribbean has received a rare in-country complex repair procedure for her spine after waiting several years on a waiting list to come to the US for treatment.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Scientists and health officials are increasing efforts to curb a drug-resistant malaria strain along the Thai-Cambodian border that is becoming increasingly resistant to artemisinin, an ingredient in artemisinin-based combination therapies, IRIN News reports.
› Verified 4 days ago
Entity Name | Wenatchee Valley Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
As part of an annual Orthopedic Surgery Mission to St. Vincent & the Grenadines, a young girl from St. Vincent in the Caribbean has received a rare in-country complex repair procedure for her spine after waiting several years on a waiting list to come to the US for treatment.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Scientists and health officials are increasing efforts to curb a drug-resistant malaria strain along the Thai-Cambodian border that is becoming increasingly resistant to artemisinin, an ingredient in artemisinin-based combination therapies, IRIN News reports.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Joshua Ventura, PHD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Joshua Ventura, PHD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 |
News Archive
As part of an annual Orthopedic Surgery Mission to St. Vincent & the Grenadines, a young girl from St. Vincent in the Caribbean has received a rare in-country complex repair procedure for her spine after waiting several years on a waiting list to come to the US for treatment.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Scientists and health officials are increasing efforts to curb a drug-resistant malaria strain along the Thai-Cambodian border that is becoming increasingly resistant to artemisinin, an ingredient in artemisinin-based combination therapies, IRIN News reports.
› Verified 4 days ago
Dr. Kasey Nicole Grass, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. James D. Goodwin, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 25 N Wenatchee Ave, #210a, Wenatchee, WA 98801 Phone: 509-663-8744 Fax: 209-231-7130 | |
Denise Mcguiness, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mr. James William Ethier, M.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 238 N. Chelan Ave., Wenatchee, WA 98801 Phone: 509-293-7727 Fax: 509-293-7728 | |
Patrick B Carrillo, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Macey M Wolfe, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Erin Harper, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |